drugset
drugset / Trial / NCT04776694

Compassionate Use or Expanded Access of Dupilumab

NCT04776694 ↗

Expanded access Available Regeneron Pharmaceuticals

Summary

Provide Compassionate Use or Expanded Access of Dupilumab

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Dupilumab Monoclonal antibody — —

Indications

No indication recorded.